Airbus Cuts 2025 Delivery Target After A320 Flaw

Airbus cuts 2025 delivery target after A320 fuselage defects, and updated guidance reassured investors, lifting U.S.-listed shares on Dec. 3, 2025.

December 03, 2025·1 min read
View all news articles
Flat vector of an A320 fuselage panel being inspected, symbolizing Airbus cuts 2025 delivery target and software fixes.

KEY TAKEAWAYS

  • Airbus cut its 2025 delivery target to about 790 aircraft after an A320 fuselage panel quality flaw.
  • The company issued updated 2025 earnings and free-cash-flow guidance that market sources called reassuring.
  • U.S.-listed shares were higher, with EADSF up 4.2% and EADSY up 4.4% at 13:15 ET.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Airbus SE cut its 2025 commercial aircraft delivery target after discovering a supplier-quality flaw in A320 fuselage panels. The defect prompted inspections and a software fix that disrupted operations, leading the company to revise its 2025 guidance on Dec. 3, 2025.

Delivery Target Cut Amid Supplier and Labor Challenges

Airbus set its 2025 delivery target at about 790 aircraft, reflecting a reduction driven mainly by a supplier-quality issue affecting metal fuselage panels on the A320 family. The company also cited broader supply-chain disruptions and worker shortages as contributing factors. The affected panels come from a Spanish-based supplier, and the flaw has delayed deliveries across hundreds of jets.

Software Update and Fleet Inspections Underway

In the week of Nov. 24, 2025, Airbus ordered a software update required on roughly 6,000 A320 jets. This update led to temporary groundings as engineers identified defects on a wider set of fuselage panels. Inspections are ongoing across hundreds of aircraft to assess the scope of the problem and determine necessary repairs.

Updated Guidance Reassures Investors Despite Delivery Cut

Alongside the delivery target reduction, Airbus issued updated 2025 earnings and free-cash-flow guidance. Market commentary described the revised outlook as reassuring to investors. U.S.-listed shares responded positively on Dec. 3, 2025, with EADSF rising 4.2% and EADSY gaining 4.4% as of 1:15 p.m. ET.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Nvidia Stock Draws Investor Attention on AI

Nvidia Stock Draws Investor Attention on AI

Nvidia stock drew investor focus after a sharp revenue surge as its AI infrastructure leadership drove flows and attention toward hardware suppliers.

Zoox Robotaxi Expansion Moves Into Phoenix, Dallas

Zoox Robotaxi Expansion Moves Into Phoenix, Dallas

Zoox robotaxi expansion adds Phoenix and Dallas and a Scottsdale Fusion Center, widening U.S. testing and sharpening investor focus on AV scaling.

Anthropic Sues DoD Over Supply-Chain Risk

Anthropic Sues DoD Over Supply-Chain Risk

Anthropic sues DoD to block a supply-chain risk designation and raises procurement questions that could complicate Claude access for defense contracts.

Oil Prices Surge After Middle East Strikes

Oil Prices Surge After Middle East Strikes

Oil prices surge after Middle East strikes and Gulf shipping disruptions drove a Brent crude rally that heightened supply and inflation risks for traders.

Live Nation Settlement Reached With DOJ

Live Nation Settlement Reached With DOJ

Live Nation settlement with the DOJ would force divestitures, open Ticketmaster to rivals and impose about $200 million in damages, pressuring fee income.

Hims & Hers Novo Nordisk Partnership Reported

Hims & Hers Novo Nordisk Partnership Reported

Reports say Hims & Hers Novo Nordisk partnership would let Hims sell Wegovy and Ozempic via telehealth and could alter revenue mix and positioning.